Growth Profiles of human autosomal trisomies at midgestation by Barr, Mason
TERATOLOGY 50:395398 (1994) 
Growth Profiles of Human Autosomal Trisomies 
at Midgestation 
MASON BARR, JR. 
Departments of Pediatrics, Pathology, and Obstetrics and Gynecology, University of Michigan, 
Ann Arbor, Michigan 48109 
ABSTRACT Somatic and visceral growth 
profiles of midgestation human fetuses with trisomy 
21, 18, or 13 demonstrate that each disorder has a 
characteristic pattern of growth aberration. The 
most striking deviations are short limbs in trisomy 
21, subnormal adrenal and lung weights in trisomy 
18, and supranormal spleen and kidney weights in 
trisomy 13. 0 1994 Wiley-Liss, Inc. 
“Dysmorphologists . . . could pay attention to the 
dysmorphology of the unborn and his membranes in  
order to recognize the circumstances which lead to 
elimination of abnormal embryos and maintenance 
of the normal” (Warkany, ’78). 
In the consideration of the pathology of the common 
human autosomal trisomies (trisomies 21, 18, and 13), 
structural abnormalities have received the lion’s share 
of attention. All three are known to be associated with 
varying degrees of intrauterine growth restriction, and 
trisomy 18 has often been cited as an example of “sym- 
metrical” growth restriction. Most studies of growth in 
particular syndromes are concerned with its character- 
ization in infants and children. Such studies typically 
include only height, weight, and head circumference. 
With the increasing use of high-resolution prenatal ul- 
trasonography, the characterization of growth during 
gestation has assumed considerable importance. The 
definition not only of gross somatic measurements 
(e.g., biparietal diameter, femur length, head and ab- 
dominal circumferences) but also those of particular 
parts or organs (e.g., kidneys, cerebellum) has been 
recognized as relevant to the diagnosis of various syn- 
dromes and other fetal conditions. 
Limb shortness in trisomy 21 has been recognized 
(Cuckle et al., ’89; Fitzsimmons et al., ’89; Rodis et al., 
’91; Benacerraf e t  al., ’91; Rotmensch et al., ’92; Nyberg 
et al., ’93). In many centers it constitutes one of the 
prenatal screening clues for the suspicion of trisomy 
21. The birth weights and postnatal growth of trisomy 
21 have been extensively studied (Pueschel et al., ’76; 
Cronk, ’78; Cronk et al., ’88), but there is little system- 
atic evaluation of growth profiles in midgestation at  
the time when ultrasonography for prenatal diagnosis 
is done. Aside from studies of birth weight and length 
of infants with several specified malformations (Ku- 
cera and Dolezalova, ’72 and ’73), there is little infor- 
mation on visceral growth in abnormal fetuses, partic- 
ularly the common autosomal trisomies. 
MATERIALS AND METHODS 
Fetuses studied were from the perinatal pathology 
data set (n=3053) of the University of Michigan Ter- 
atology Unit. Selection criteria were: absence of mac- 
eration, body weight between 100 and lOOOg, karyo- 
type confirmed from amniocytes and i or fetal tissues, 
and morphology consistent with the cytogenetic diag- 
nosis. From a pool of 89 cases of trisomy 21, 68 met the 
selection criteria; from a pool of 45 trisomy 18s, 25 met 
the criteria; and from a pool of 28 trisomy 13s, 12 met 
the criteria. Of these 12, four had no holoprosencephaly 
and eight had alobar holoprosencephaly; the latter 
were compared with three cases with alobar holo- 
prosencephaly that had normal karyotypes and no 
other malformations. 
In order to determine the normalityiabnormality of 
the morphometrics in aneuploid fetuses it was first nec- 
essary to develop standards for “normal” (more cor- 
rectly, “typical”) fetuses. This has been done and re- 
ported previously (Barr et al., ’94). Using these growth 
parameters, Z-scores (observed minus expected, di- 
vided by the standard deviation) were computed for 
selected somatic measurements (body weight, crown- 
heel and crown-rump lengths, head circumference, and 
arm, leg and foot lengths) and selected viscera weights 
(brain, spleen, thymus, thyroid, heart, liver, adrenals, 
kidneys, and lungs), using body weight and brain 
weight as the independent variables. Mean standard 
scores and their standard deviations for each syndrome 
were computed. Although statistical testing for signif- 
icant differences from the expected values was done, 
using two-tailed t-tests, this seemed to overstate the 
case for growth aberration simply because of the large 
Received September 12, 1994; accepted November 21, 1994. 
Address reprint requests to Mason Barr, Jr., M.D., Pediatric-Genet- 
ics-Teratology Unit, D1109 MPB 0718, University of Michigan Med- 
ical Center, Ann Arbor, MI 48109-0718. 
0 1994 WILEY-LISS, INC. 
396 M.BARR 
sample size of the controls (n 1014). Accordingly, prob- 
ability values are not displayed in the figures, but the 
reader is left to visually assess the magnitude of the 
deviations of the observed means from those expected. 
It is felt that a suitable criterion for biologically mean- 
ingful aberration is an  observed mean greater than one 
standard deviation above or below the expected mean. 
RESULTS 
In trisomy 21 (Fig. 11, there is an overall depression 
of both somatic measurements and visceral weights by 
body weight standards. This is judged to be the result of 
mild edema often present a t  this stage of gestation (al- 
though the edema may, on occasion, be severe enough 
to qualify as  hydrops fetalis). When judged by brain 
weight standards, somatic measurements tend to be 
elevated, with the exception that limb lengths are re- 
duced. As noted by others, the limb length reduction in 
trisomy 21 is more pronounced for the arms than the 
legs. It is also noted that there is a discordance between 
head circumference and brain weight; this is correlated 
with an apparent excess of extracerebral CSF, al- 
though fluid volumes have not actually been measured 
to verify this observation. When visceral weights are 
considered by brain weight standards, the major devi- 
ations are depressions of adrenal and lung weights. 
These reductions, while statistically significant, are 
not of a degree that would predict any particular clin- 
ical correlates for the neonate with trisomy 21, nor, 
except for the short limbs, would they be detectable by 
prenatal ultrasonography. 
In trisomy 18 (Fig. 21, deviations from normal mor- 
phometrics are more pronounced than in trisomy 21. 
Both trunk and limbs are appreciably shorter. Head 
circumference is mildly elevated for body weight, and 
this is accompanied by a brain weight that is also ex- 
cessive for body weight. Among the fetuses examined 
there were no instances of hydrocephaly. The pheno- 
type of trisomy 18 is not uncommonly described as in- 
cluding a small face. These data suggest the problem 
may be more accurately the disproportion between 
head and face, with the head size matching gestational 
age and the face matching the small body. Among the 
viscera in trisomy 18, spleen weight is elevated (al- 
though the variance is rather large), while liver, adre- 
nal and lung weights are reduced. 
The analysis of trisomy 13 fetuses (Fig. 3) was con- 
founded by the presence or absence of alobar holo- 
prosencephaly. Accordingly, the sample of fetuses with 
trisomy 13 was subdivided based on this brain malfor- 
mation. Those without holoprosencephaly have rather 
normal somatic measurements, although their head 
circumferences and brain weights are demonstrably 
subnormal. In this subset, visceral weight aberrations 
are most pronounced for splenomegaly and renomegaly 
(note that no cases of cystic renal dysplasia were in- 
cluded in the sample). Among trisomy 13 fetuses with 
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Fig. 1. Growth profiles for trisomy 21. 
Bdy body weight 
CHL crown-heel length 
CRL crown-rump length 
OFC head circumference 
Arm armlength 
Leg leg length 
FTL foot length 
Brn brain weight 
Spl spleen weight 
Tym thymus weight 
Tyr thyroid weight 
Hrt heart weight 
Liv liver weight 
Adr adrenal weight (combined) 
Kid kidney weight (combined) 
Lng lung weight (combined). 
Details of measurements are as in Barr et  al. (’94). On the X-axis, 
the independent variable is placed before the colon and the dependent 
variable (or standard) after. 
The bars represent the observed mean 5 one standard deviation; 
the comparable range for the control fetuses is the distance between a 
Z-score of 1.0 to  - 1.0, with Z = 0 being the expected mean. The bars 
are connected only to  emphasize the pattern when comparing one 
syndrome with another (Poznanski et  al., ’72). 
alobar holoprosencephaly, head circumference and 
brain weight are drastically reduced, as expected.* 
Loss of normal cranial dimensions is also reflected in a 
decreased crown-rump length. The splenomegaly and 
renomegally seen in the nonholoprosencephalic subset 
are found in these fetuses as well (again no cases of 
*However, with alobar holoprosencephaly head circumference may be 
quite variable, spanning the range from macrocephalic (hydroceph- 
aly) to profound microcephaly. 
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Fig. 2. Growth profiles for trisomy 18. See legend of Fig. 1 for 
explanation. 
cystic renal dysplasia were included in the sample). In 
both subsets, thymus and heart weights are reduced, 
while lung weight is reduced only in those with the 
major brain anomaly. 
DISCUSSION 
"Phenotype" typically refers to structural features, 
although for some syndromes growth and functional 
features are key components. Many factors influence 
prenatal growth, including heritable factors, environ- 
mental factors, and factors intrinsic to the conceptus. 
Growth aberrations may be somatic or visceral, gener- 
alized or localized, transient or permanent, accelerated 
or restricted, andlor of early or late onset. They may be 
correlated, singly or in combination, with structural 
abnormalities, functional abnormalities, death, or pre- 
mature delivery. 
What is to be made of the growth data presented 
here? Some of the aberrations are of such a nature that 
they could be useful in the in utero ultrasonographic 
screening of fetuses for autosomal trisomy. This is al- 
ready the case for trisomy 21, the most prevalent of the 
trisomies at midgestation. The shortness of both the 
arms and legs has been noted, but by themselves short 
limbs are not highly specific indicators of trisomy 21 
(Cuckle et al., '89: Fitzsimmons et al., '89; Rodis et al., 
'91; Benacerraf et al., '91; Rotmensch et al., '92; Nyberg 
et al., '93). To reduce the number of women advised to 
undergo amniocentesis, while maintaining or increas- 
ing the detection of trisomy 21, various combinations of 
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Fig. 3. Growth profiles for trisomy 13, with and without alobar 
holoprosencephaly, and for euploid fetuses with alobar holoprosen- 
cephaly. See legend of Fig. 1 for explanation. 
limb measurements have been proposed to increase the 
specificity and sensitivity of ultrasonographic screen- 
ing (Johnson et al., '93a, '93b, 94). 
While growth aberrations may most commonly be 
inherent to the genotype, it is suspected that a t  least 
some could be reflections of altered fetal physiology. 
Such disturbances in fetal physiology may not be spe- 
cific to any one syndrome, but might have general ap- 
plication irrespective of the syndrome. If that is true, 
finding a particular growth anomaly might be a tipoff 
to a physiologic derangement and allow a focused ap- 
proach to fetal therapy. 
Some of the observed patterns suggest the need for 
investigation of the interaction between physiology 
and growth of the trisomic fetus. In the case of trisomy 
13 fetuses, could reduced lung weight be a consequence 
of reduced fetal breathing activity associated with holo- 
prosencephaly? On the other hand, fetuses with iso- 
lated alobar holoprosencephaly do not show evidence of 
lung undergrowth. Other than having comparable de- 
grees of reduced head circumference and brain weight, 
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euploid fetuses with holoprosencephaly show no 
growth pattern similarities to the trisomy 13 fetuses. 
The reason for the spenomegaly and renomegaly in tri- 
somy 13 remains to be discovered. 
Trisomy 18 is often cited as  an archetypal example of 
“symmetrical” intrauterine growth restriction. These 
data indicate that in trisomy 18, a t  midgestation, the 
growth aberration is anything but symmetrical 
(Johnson et al., ’89). The lung and adrenal weights are 
often reduced to a degree that suggests the neonate 
with trisomy 18 may experience physiological prob- 
lems with lung and adrenal function. This may in turn 
contribute to the early neonatal lethality of this syn- 
drome. 
It is to be noted that each of the three autosomal 
trisomies covered in this report has its own distinctive 
pattern of somatic and visceral growth. These patterns 
have been helpful in making a diagnosis in fetuses sub- 
mitted for examination when no material for cytoge- 
netic study is available (i.e., formalin fixation or severe 
maceration). I t  is cautioned that the patterns reported 
here apply only to the midgestation fetus. There is 
some evidence that the characteristics of these pat- 
terns may change by term, reflecting some potential 
for either “catch-up” growth or later-onset growth re- 
striction (Johnson et al., ’89). To date, the sample size 
of aneuploid term infants from my collection is insuf- 
ficient to make any definitive assessment of these pos- 
sibilities. 
The finding of an  autosomal trisomy is often consid- 
ered an adequate explanation of fetal or neonatal 
death. However, as pointed out by Rushton (’851, the 
mere existence of a karyotypic anomaly does not really 
explain why that particular death occurred. We should 
be better informed if we understood whether or not the 
presence of small adrenals, small hearts, small lungs, 
large spleens, or large kidneys has anything to do with 
the clinical course. If, as Hook (’79) has estimated, 23% 
of trisomy 21 fetuses die between midgestation and 
term, our question should be why and how do they die? 
Warkany (’78) coined the term terathanasia in recog- 
nition of the general lethality of many malformations 
and anomalies. He suggested that, if nature generally 
aborts abnormal fetuses, perhaps the survival of some 
represents a failure of the natural screening process 
and the reasons for this failure would be worthy of 
study. The data from this study do not permit a dis- 
tinction between spontaneously and medically aborted 
fetuses, but they do extend the description of the dys- 
morphology of the aut.osoma1 trisomies. The finding of 
aberrant growth patterns suggests additional useful 
points to look for answers to Warkany’s challenge. 
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